These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21294768)

  • 1. Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).
    Marcovecchio ML; Widmer B; Turner C; Dunger DB; Dalton RN
    Diabet Med; 2011 Jun; 28(6):685-91. PubMed ID: 21294768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.
    Sibal L; Agarwal SC; Schwedhelm E; Lüneburg N; Böger RH; Home PD
    Cardiovasc Diabetol; 2009 Jun; 8():27. PubMed ID: 19486510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
    Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes.
    Marcovecchio ML; Widmer B; Dunger DB; Dalton RN
    Clin Sci (Lond); 2008 Dec; 115(12):361-9. PubMed ID: 18498242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.
    Sugawara A; Kawai K; Motohashi S; Saito K; Kodama S; Yachi Y; Hirasawa R; Shimano H; Yamazaki K; Sone H
    Diabetologia; 2012 Aug; 55(8):2128-31. PubMed ID: 22580991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy.
    Päivä H; Lehtimäki T; Laakso J; Ruokonen I; Rantalaiho V; Wirta O; Pasternack A; Laaksonen R
    Metabolism; 2003 Mar; 52(3):303-7. PubMed ID: 12647267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine is negatively correlated with hyperglycemia in children.
    Takaya J; Tanabe Y; Kuroyanagi Y; Kaneko K
    Endocr J; 2015; 62(6):551-6. PubMed ID: 25903645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control.
    Hsu CP; Hsu PF; Chung MY; Lin SJ; Lu TM
    Cardiovasc Diabetol; 2014 Dec; 13():156. PubMed ID: 25467091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus.
    Chrysis D; Efthymiadou A; Mermigka A; Kritikou D; Spiliotis BE
    Pediatr Diabetes; 2017 Jun; 18(4):277-282. PubMed ID: 27028343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes.
    Marcovecchio ML; Dalton RN; Turner C; Prevost AT; Widmer B; Amin R; Dunger DB
    Arch Dis Child; 2010 Feb; 95(2):119-24. PubMed ID: 19948509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoglobin A1c is not a surrogate for glucose and insulin measures for investigating the early life and childhood determinants of insulin resistance and Type 2 diabetes in healthy children. An analysis from the Avon Longitudinal Study of Parents and Children (ALSPAC).
    Shultis WA; Leary SD; Ness AR; Scott J; Martin RM; Whincup PH; Smith GD;
    Diabet Med; 2006 Dec; 23(12):1357-63. PubMed ID: 17116188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
    Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
    Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
    Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
    Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.
    Hsu CC; Chang HY; Huang MC; Hwang SJ; Yang YC; Lee YS; Shin SJ; Tai TY
    Diabetologia; 2012 Dec; 55(12):3163-72. PubMed ID: 22923064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.
    Krzyzanowska K; Mittermayer F; Shnawa N; Hofer M; Schnabler J; Etmüller Y; Kapiotis S; Wolzt M; Schernthaner G
    Diabet Med; 2007 Jan; 24(1):81-6. PubMed ID: 17227328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.
    Altinova AE; Arslan M; Sepici-Dincel A; Akturk M; Altan N; Toruner FB
    J Clin Endocrinol Metab; 2007 May; 92(5):1881-5. PubMed ID: 17311854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Asymmetric dimethylarginine (ADMA) in children with diabetes type 1].
    Głowińska-Olszewska B; Luczyński W; Jabłońska J; Otocka A; Florys B; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2010; 16(3):137-41. PubMed ID: 21092689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum sialic acid with cardiovascular metabolic risk factors in Kuwaiti children and adolescents with type 1 diabetes.
    Moussa MA; Alsaeid M; Refai TM; Abdella N; Al-Sheikh N; Gomez JE
    Metabolism; 2004 May; 53(5):638-43. PubMed ID: 15131770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.